Cannabis Use Characteristics and PTSD-Related Outcomes Among Canadian Veterans With Chronic Pain
References
- Afanador, N. L., Tran, T., Blanchet, L., & Baumgartner, R. (2022, October 5). mvdalab: Multivariate Data Analysis Laboratory. The Comprehensive R Archive Network.
https://CRAN.R-project.org/package=mvdalab - Allan, G. M., Ramji, J., Perry, D., Ton, J., Beahm, N. P., Crisp, N., Dockrill, B., Dubin, R. E., Findlay, T., Kirkwood, J., Fleming, M., Makus, K., Zhu, X., Korownyk, C., Kolber, M. R., McCormack, J., Nickel, S., Noël, G., & Lindblad, A. J. (2018). Simplified guideline for prescribing medical cannabinoids in primary care. Canadian Family Physician, 64(2), 111–120.
https://pubmed.ncbi.nlm.nih.gov/29449241/ - American Psychiatric Association. (2022). Trauma- and stressor-related disorders. In American Psychiatric Association (Ed.), Diagnostic and statistical manual of mental disorders (5th ed., text rev.). 10.1176/appi.books.9780890425787.x07_Trauma_and_Stressor_Related_Disorders
- American Psychological Association. (2017). Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults.
https://www.apa.org/ptsd-guideline/ptsd.pdf - Arkell, T. R., Lintzeris, N., Kevin, R. C., Ramaekers, J. G., Vaney, R., Irwin, C., Haber, P. S., & McGregor, I. S. (2019). Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology, 236(9), 2713–2724. 10.1007/s00213-019-05246-8
- Atlas Institute. (2022). Insights into veteran and veteran family experiences with cannabis and mental health.
https://atlasveterans.ca/documents/cannabis-dialogue-series-summary-en.pdf - Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297–307. 10.1016/S1389-9457(00)00065-4
- Benedict, T. M., Keenan, P. G., Nitz, A. J., & Moeller-Bertram, T. (2020). Post-traumatic stress disorder symptoms contribute to worse pain and health outcomes in veterans with PTSD compared to those without: A systematic review with meta-analysis. Military Medicine, 185(9–10), e1481–e1491. 10.1093/milmed/usaa052
- Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B, Methodological, 57(1), 289–300. 10.1111/j.2517-6161.1995.tb02031.x
- Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The posttraumatic stress disorder checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation: Posttraumatic stress disorder checklist for DSM-5. Journal of Traumatic Stress, 28(6), 489–498. 10.1002/jts.22059
- Bonn-Miller, M. O., Sisley, S., Riggs, P., Yazar-Klosinski, B., Wang, J. B., Loflin, M. J. E., Shechet, B., Hennigan, C., Matthews, R., Emerson, A., & Doblin, R. (2021). The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PloS One, 16(3),
e0246990 . 10.1371/journal.pone.0246990 - Bovin, M. J., Marx, B. P., Weathers, F. W., Gallagher, M. W., Rodriguez, P., Schnurr, P. P., & Keane, T. M. (2016). Psychometric properties of the PTSD checklist for diagnostic and statistical manual of mental disorders-fifth edition (PCL-5) in veterans. Psychological Assessment, 28(11), 1379–1391. 10.1037/pas0000254
- Cannabis Act, SC 2018, c 16. (2018).
https://laws-lois.justice.gc.ca/eng/acts/C-24.5/FullText.html - Chan, S., Blake, A., Wolt, A., Wan, B. A., Zaki, P., Zhang, L., Lam, H., Slaven, M., Shaw, E., Deangelis, C., Ganesh, V., Malek, L., Chow, E., & O’Hearn, S. (2017). Medical cannabis use for patients with post-traumatic stress disorder (Ptsd). Journal of Pain Management, 10(4), 385–396.
https://www.proquest.com/docview/2190033274?sourcetype=Scholarly%20Journals - Drennan, M. L., Karoly, H. C., Bryan, A. D., Hutchison, K. E., & Bidwell, L. C. (2021). Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates. Scientific Reports, 11(1),
21744 . 10.1038/s41598-021-01128-2 - Drost, L., Wan, B. A., Blake, A., Chan, S., Wolt, A., Ganesh, V., Zhang, L., Slaven, M., Shaw, E., Deangelis, C., Lam, H., Zaki, P., Malek, L., Chow, E., & O’hearn, S. (2017). Efficacy of different varieties of medical cannabis in relieving symptoms in post-traumatic stress disorder (Ptsd) patients. Journal of Pain Management, 10(4), 415–422.
https://openurl.ebsco.com/EPDB%3Agcd%3A8%3A16750792/detailv2?sid=ebsco%3Aplink%3Ascholar&id=ebsco%3Agcd%3A129041545&crl=c&link_origin=www.google.com - El-Gabalawy, R., Blaney, C., Tsai, J., Sumner, J. A., & Pietrzak, R. H. (2018). Physical health conditions associated with full and subthreshold PTSD in U.S. military veterans: Results from the national health and resilience in veterans study. Journal of Affective Disorders, 227, 849–853. 10.1016/j.jad.2017.11.058
- Elms, L., Shannon, S., Hughes, S., & Lewis, N. (2019). Cannabidiol in the treatment of post-traumatic stress disorder: A case series. The Journal of Alternative and Complementary Medicine, 25(4), 392–397. 10.1089/acm.2018.0437
- Fabritius, M., Chtioui, H., Battistella, G., Annoni, J-M., Dao, K., Favrat, B., Fornari, E., Lauer, E., Maeder, P., & Giroud, C. (2013). Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint. Analytical and Bioanalytical Chemistry, 405(30), 9791–9803. 10.1007/s00216-013-7412-1
- Fraser, G. A. (2009). The use of a synthetic cannabinoid in the management of treatment resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neuroscience & Therapeutics, 15(1), 84–88. 10.1111/j.1755-5949.2008.00071.x
- Friedrich, S., Konietschke, F., & Pauly, M. (2019). Resampling-based analysis of multivariate data and repeated measures designs with the R package MANOVA.RM. The R Journal, 11(2), 380–400. 10.32614/RJ-2019-051
- Gauvin, D. E., Wolfson, C., Aiken, A. B., Feinstein A., Raina, P., & VanTil, L. D. (2021). Correlates of posttraumatic stress disorder among veterans in the Canadian longitudinal study on aging. Journal of Military, Veteran and Family Health, 8(1), 38–55. 10.3138/jmvfh-2021-0030
- Graham, J., Legarreta, M., North, L., DiMuzio, J., McGlade, E., & Yurgelun-Todd, D. (2016). A preliminary study of DSM–5 PTSD symptom patterns in veterans by trauma type. Military Psychology, 28(2), 115–122. 10.1037/mil0000092
- Han, K., Wang, J.-Y., Wang, P.-Y., & Peng, Y.-C.-H. (2024). Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis. Psychiatry Research, 339,
116049 . 10.1016/j.psychres.2024.116049 - Jetly, R., Heber, A., Fraser, G., & Boisvert, D. (2015). The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology, 51, 585–588. 10.1016/j.psyneuen.2014.11.002
- Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. The American Journal of Psychiatry, 142(11), 1259–1264. 10.1176/ajp.142.11.1259
- Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. 10.3109/10673229709030550
- Kind, S., & Otis, J. D. (2019). The interaction between chronic pain and PTSD. Current Pain and Headache Reports, 23(12), 1–7. 10.1007/s11916-019-0828-3
- Klumpers, L. E., & Thacker, D. L. (2019). A brief background on cannabis: From plant to medical indications. Journal of AOAC International, 102(2), 412–420. 10.5740/jaoacint.18-0208
- Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. 10.1046/j.1525-1497.2001.016009606.x
- Kroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016). Patient health questionnaire anxiety and depression scale: Initial validation in three clinical trials. Psychosomatic Medicine, 78(6), 716–727. 10.1097/PSY.0000000000000322
- LaFrance, E. M., Glodosky, N. C., Bonn-Miller, M., & Cuttler, C. (2020). Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder. Journal of Affective Disorders, 274, 298–304. 10.1016/j.jad.2020.05.132
- Lake, S., Kerr, T., Buxton, J., Walsh, Z., Marshall, B. D., Wood, E., & Milloy, M. J. (2020). Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians. Journal of Psychopharmacology (Oxford), 34(2), 181–188. 10.1177/0269881119882806
- Larsen, S. E., Wiltsey Stirman, S., Smith, B. N., & Resick, P. A. (2016). Symptom exacerbations in trauma-focused treatments: Associations with treatment outcome and non-completion. Behaviour Research and Therapy, 77, 68–77. 10.1016/j.brat.2015.12.009
- Lehavot, K., Katon, J. G., Chen, J. A., Fortney, J. C., & Simpson, T. L. (2018). Post-traumatic stress disorder by gender and veteran status. American Journal of Preventive Medicine, 54(1), e1–e9. 10.1016/j.amepre.2017.09.008
- Little, R. J. A. (1988). A test of missing completely at random for multivariate data with missing values. Journal of the American Statistical Association, 83(404), 1198–1202. 10.1080/01621459.1988.10478722
- Lo, L. A., Christiansen, A. L., Strickland, J. C., Pistawka, C. A., Eadie, L., Vandrey, R., & MacCallum, C. A. (2024). Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC). Neuropsychopharmacology, 49(9), 1425–1436. 10.1038/s41386-024-01847-w
- Mahmood, F., Lim, M. M., & Kirchhof, M. G. (2022). A survey of topical cannabis use in Canada. Journal of Cutaneous Medicine and Surgery, 26(2), 156–161. 10.1177/12034754211059025
- Manhapra, A., Stefanovics, E., & Rosenheck, R. (2015). Treatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence. Drug and Alcohol Dependence, 156, 70–77. 10.1016/j.drugalcdep.2015.08.036
- Metrik, J., Stevens, A. K., Gunn, R. L., Borsari, B., & Jackson, K. M. (2022). Cannabis use and posttraumatic stress disorder: Prospective evidence from a longitudinal study of veterans. Psychological Medicine, 52(3), 446–456. 10.1017/S003329172000197X
- Morgan, C. J. A., Freeman, T. P., Hindocha, C., Schafer, G., Gardner, C., & Curran, H. V. (2018). Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Translational Psychiatry, 8(1),
181 . 10.1038/s41398-018-0191-x - Morin, C. M., Belleville, G., Bélanger, L., & Ivers, H. (2011). The insomnia severity index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep, 34(5), 601–608. 10.1093/sleep/34.5.601
- Nacasch, N., Avni, C., & Toren, P. (2023). Medical cannabis for treatment-resistant combat PTSD. Frontiers in Psychiatry, 13,
1014630 . 10.3389/fpsyt.2022.1014630 - Papini, S., Ruglass, L. M., Lopez-Castro, T., Powers, M. B., Smits, J. A. J., & Hien, D. A. (2017). Chronic cannabis use is associated with impaired fear extinction in humans. Journal of Abnormal Psychology, 126(1), 117–124. 10.1037/abn0000224
- Prins, A., Bovin, M. J., Smolenski, D. J., Marx, B. P., Kimerling, R., Jenkins-Guarnieri, M. A., Kaloupek, D. G., Schnurr, P. P., Kaiser, A. P., Leyva, Y. E., & Tiet, Q. Q. (2016). The primary care PTSD screen for DSM-5 (PC-PTSD-5): Development and evaluation within a veteran primary care sample. Journal of General Internal Medicine, 31(10), 1206–1211. 10.1007/s11606-016-3703-5
- Raymundi, A. M., da Silva, T. R., Sohn, J. M. B., Bertoglio, L. J., & Stern, C. A. (2020). Effects of Δ 9-tetrahydrocannabinol on aversive memories and anxiety: A review from human studies. BMC Psychiatry, 20(1),
420 . 10.1186/s12888-020-02813-8 - Roitman, P., Mechoulam, R., Cooper-Kazaz, R., & Shalev, A. (2014). Preliminary, open-label, pilot study of add-on oral Δ- tetrahydrocannabinol in chronic post-traumatic stress disorder. Clinical Drug Investigation, 34(8), 587–591. 10.1007/s40261-014-0212-3
- Rosencrans, P. L., Zoellner, L. A., & Feeny, N. C. (2024). A network approach to posttraumatic stress disorder: Comparing interview and self-report networks. Psychological Trauma: Theory, Research, Practice and Policy, 16(2), 340–346. 10.1037/tra0001151
- Ruglass, L. M., Shevorykin, A., Radoncic, V., Smith, K. M. Z., Smith, P. H., Galatzer-Levy, I. R., Papini, S., & Hien, D. A. (2017). Impact of cannabis use on treatment outcomes among adults receiving cognitive-behavioral treatment for PTSD and substance use disorders. Journal of Clinical Medicine, 6(2),
14 . 10.3390/jcm6020014 - Sainsbury, B., Bloxham, J., Pour, M. H., Padilla, M., & Enciso, R. (2021). Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis. Journal of Dental Anesthesia and Pain Medicine, 21(6), 479–506. 10.17245/jdapm.2021.21.6.479
- Schlienz, N. J., Spindle, T. R., Cone, E. J., Herrmann, E. S., Bigelow, G. E., Mitchell, J. M., Flegel, R., LoDico, C., & Vandrey, R. (2020). Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence, 211,
107969 . 10.1016/j.drugalcdep.2020.107969 - Schnurr, P. P., Lunney, C. A., Bovin, M. J., & Marx, B. P. (2009). Posttraumatic stress disorder and quality of life: Extension of findings to veterans of the wars in Iraq and Afghanistan. Clinical Psychology Review, 29(8), 727–735. 10.1016/j.cpr.2009.08.006
- Smith, P. A., Chan, S., Blake, A., Wolt, A., Zhang, L., Wan, B. A., Zaki, P., Lam, H., Deangelis, C., Slaven, M., Shaw, E., Ganesh, V., Malek, L., Chow, E., & O’Hearn, S. (2017). Medical cannabis use in military and police veterans diagnosed with post-traumatic stress disorder (PTSD). Journal of Pain Management, 10(4), 397–405.
- Smith, S. M., Goldstein, R. B., & Grant, B. F. (2016). The association between post-traumatic stress disorder and lifetime DSM-5 psychiatric disorders among veterans: Data from the national epidemiologic survey on alcohol and related conditions-III (NESARC-III). Journal of Psychiatric Research, 82, 16–22. 10.1016/j.jpsychires.2016.06.022
- Solowij, N., Broyd, S., Greenwood, L-M., van Hell, H., Martelozzo, D., Rueb, K., Todd, J., Liu, Z., Galettis, P., Martin, J., Murray, R., Jones, A., Michie, P. T., & Croft, R. (2019). A randomised controlled trial of vaporised Δ 9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 17–35. 10.1007/s00406-019-00978-2
- Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. 10.1001/archinte.166.10.1092
- Sterniczuk, R., & Whelan, J. (2016). Cannabis use among Canadian Armed Forces veterans. Journal of Military, Veteran and Family Health, 2(2), 43–52. 10.3138/jmvfh.3836
- Storey, D. P., Keeler-Villa, N. R., Harris, N., Anthonypillai, J., Tippin, G. K., Parihar, V., & Rash, J. A. (2023). Views on and experiences with medicinal cannabis among Canadian Veterans who live with pain: A qualitative study. Canadian Journal of Pain, 7(1),
2232838 . 10.1080/24740527.2023.2232838 - Tabachnick, B. G., & Fidell, L. S. (2019). Using multivariate statistics (7th ed.). Pearson.
- Thompson J., MacLean, M. B., Til, L. V., Sweer, J., Poirier, A., & Pedlar, D. (2011, January 4). Survey on transition to civilian life: Report on regular force veterans. Research Directorate, Veterans Affairs Canada.
https://publications.gc.ca/collections/collection_2011/acc-vac/V32-231-2011-eng.pdf - Thompson, J., VanTil, L., Sweet, J., Poirier, A., McKinnon, K., Dursun, S., Sudom, K., Zamorski, M., Sareen, J., Ross, D., Hoskins, C., & Pedlar, D. (2015, March 19). Canadian Armed Forces veterans: Mental health findings from the 2013 life after service survey. Research Directorate, Veterans Affairs Canada.
https://publications.gc.ca/collections/collection_2016/acc-vac/V32-260-2016-eng.pdf - US Department of Veterans Affairs & Department of Defense. (2017). VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder (Version 3.0).
https://www.healthquality.va.gov/guidelines/MH/ptsd/VADoDPTSDCPGFinal012418.pdf - Valikhanova, G., Kato, Y., Fitzcharles, M-A., Ware, M., Da Costa, D., Lowensteyn, I., Cheung, H. S., & Grover, S. (2023). Medical cannabis use among Canadian veterans and non-veterans: A national survey. Integrative Medicine Reports, 2(1), 120–128. 10.1089/imr.2023.0022
- Van Buuren, S., & Groothuis-Oudshoorn, K. (2011). Mice: Multivariate imputation by chained equations in R. Journal of Statistical Software, 45(3), 1–67. 10.18637/jss.v045.i03
- Veterans Affairs Canada. (2019, October 17). Reimbursement policy for cannabis for medical purposes.
https://www.veterans.gc.ca/eng/about-vac/legislation-policies/policies/document/2461 - Veterans Affairs Canada. (2023, May 30). Cannabis for medical purposes.
https://www.veterans.gc.ca/eng/about-vac/research/research-directorate/publications/reports/cmp - Walker, R. S. W., Marks, E. H., Jaeger, J., Duax, J. M., Feeny, N. C., & Zoellner, L. A. (2020). Imaginal exposure exacerbation revisited: Deconstructing patient characteristics associated with worse reactions to the initiation of imaginal exposure in PTSD. Behaviour Research and Therapy, 135,
103747 . 10.1016/j.brat.2020.103747 - Wallace, M., Schulteis, G., Atkinson, J. H., Wolfson, T., Lazzaretto, D., Bentley, H., Gouaux, B., & Abramson, I. (2007). Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology (Philadelphia), 107(5), 785–796. 10.1097/01.anes.0000286986.92475.b7
- Wilcox, R. R. (2017). Introduction to robust estimation and hypothesis testing (4th ed.). Elsevier.
- Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015). Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder. The Journal of Clinical Psychiatry, 76(9), 1174–1180. 10.4088/JCP.14m09475
- Zehra, A., Burns, J., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. J. (2018). Cannabis addiction and the brain: A review. Journal of Neuroimmune Pharmacology, 13(4), 438–452. 10.1007/s11481-018-9782-9
DOI: https://doi.org/10.21061/jvs.v11i1.582 | Journal eISSN: 2470-4768
Language: English
Page range: 30 - 46
Submitted on: Jul 6, 2024
Accepted on: Nov 23, 2024
Published on: Jan 27, 2025
Published by: Virginia Tech Publishing
In partnership with: Paradigm Publishing Services
Keywords:
© 2025 Mitchell R. Sheehy, David P. Storey, Joshua A. Rash, Greg K. Tippin, Vikas Parihar, Nick Harris, published by Virginia Tech Publishing
This work is licensed under the Creative Commons Attribution 4.0 License.